Low-density lipoprotein size, pravastatin treatment, and coronary events

JAMA

Volumn 286, Issue 12, 2001, Pages 1468-1474

  Campos, Hannia ^a   Moye, Lemuel A ^d   Glasser, Stephen P ^e   Stampfer, Meir J ^b   Sacks, Frank M ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; SURVIVAL; TREATMENT PLANNING;

EID: 0035955042     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.12.1468     Document Type: Article

References (37)

1. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease
2. Low-density lipoprotein subclass patterns and risk of myocardial infarction
3. Relationships of low density lipoprotein subfractions to angiographically defined coronary disease in young survivors of myocardial infarction
4. Low density lipoprotein particle size and coronary artery disease
5. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women
6. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease
7. Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease
8. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians: The Strong Heart Study
9. Risk factors for coronary heart disease in a population with a high prevalence of obesity and diabetes: A case-control study of the Polynesian population of Western Samoa
10. Smaller, denser LDL particles are not a risk factor for cardiovascular disease in healthy nonagenarian women of the Cremona Population Study
11. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women
12. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
13. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: Prospective results from the Quebec Cardiovascular Study
14. LDL size and risk of coronary heart disease in elderly men and women
15. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk
16. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome
17. Small, dense low-density lipoprotein particles and coronary heart disease risk: A clear association with uncertain implications
18. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
19. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
20. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: Results of the Framingham Offspring Study
21. Characterization of low-density lipoprotein subclasses: Methodologic approaches and clinical relevance
22. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial
23. Urbanization elicits a more atherogenic lipoprotein profile in carriers of the apolipoprotein A-IV-2 allele than in A-IV-1 homozygotes
24. Defective catabolism and abnormal composition of low-density lipoproteins from mutant pigs with hypercholesterolemia
25. Lipoproteins and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates: Role of cholesterol and fatty acids
26. Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men
27. Dietary polyunsaturated fat decreases interaction between low density lipoproteins and arterial proteoglycans
28. Differential effects of isolated lipoproteins from normal and hypercholesterolemic rhesus monkeys on cholesterol esterification and accumulation in the arterial smooth muscle cells in culture
29. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor
30. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women
31. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects
32. Pravastatin effectively lowers LDL cholesterol in familial combined hypedipidemia without changing LDL subdass pattern
33. West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials
34. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: The prospective pravastatin pooling project
35. Plasma triglyceride determines structure-composition in low and high density lipoproteins
36. Lipoprotein heterogeneity and apolipoprotein B metabolism